Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

about

Salivary secretory immunoglobulin A reactivity: a comparison to cortisol and α-amylase patterns in the same breast cancer survivors

P2860

Q59129070-ECD633A8-7A66-491C-8E4B-BC6FD708A6B7

P2860

Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

Item

http://www.wikidata.org/entity/Q41542251

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Anti-GP2 IgA: a biomarker for ...... rimary sclerosing cholangitis?

@en

type

Item

label

Anti-GP2 IgA: a biomarker for ...... rimary sclerosing cholangitis?

@en

prefLabel

Anti-GP2 IgA: a biomarker for ...... rimary sclerosing cholangitis?

@en

P1476

Anti-GP2 IgA: a biomarker for ...... rimary sclerosing cholangitis?

@en

P2093

Ju Dong Yang

http://www.w3.org/2001/XMLSchema#string

Sumera Rizvi

http://www.w3.org/2001/XMLSchema#string

P2860

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.

Update on biomarkers of hepatocellular carcinoma.

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.

Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.

Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.

Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.

The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.

P304

4-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2016-312492

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gregory J Gores

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27587361

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

cholangitis

biomarker

P932

5574160

http://www.w3.org/2001/XMLSchema#string

Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

about

P2860

P2860

Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932